All Insights
Exploring the science, practice, and business of medicine.
Search and Filter Insights
Showing 10 out of 38 Insights
-
Active Filters
-
Why Does the World's Most Expensive Health Care System Fall Short on Health Outcomes?
HealthSpark, Episode 28: Benjamin Rome, an assistant professor of medicine at Harvard Medical School and a health policy researcher at Brigham and Women's Hospital, illuminates how fragmented incentives, high prices, and policy choices make US health care so expensive and what it will take to change that.
-
How GLP-1 Therapies Are Transforming Health Care and the Future of Care Delivery
While GLP-1–based therapies are expanding from diabetes treatment to broad multi-system care, their growing complexity is reshaping clinical collaboration, health system organization, and the ongoing challenge of making these transformative medications affordable and accessible.
-
What Happens When Only Some Parts of the World Can Respond to Disease Outbreaks?
HealthSpark, Episode 27: Christopher Carter, molecular epidemiologist at the Kansas Department of Health and Environment, examines how pathogen genomic sequencing can strengthen disease surveillance and why equitable global access to epidemiological tools is so important for global health security.
-
Are Current Medical Device Regulations Obsolete in an AI-driven, Digital Health Future?
HealthSpark, Episode 26: Ariel Stern, Alexander von Humboldt Professor for Digital Health, Economics, and Policy at the Hasso Plattner Institute and Professor at the University of Potsdam, examines how rapidly evolving algorithms and digital therapeutics are challenging legacy oversight systems, and what smarter, more adaptive policy approaches may require.
-
Can Addressing One Disease Transform Global Health?
HealthSpark, Episode 25: Fatima Cody Stanford, an obesity medicine physician scientist at Massachusetts General Hospital and Harvard Medical School, reflects on why obesity is one of modern medicine's most complex challenges and how coordinated action across care delivery, public health, and industry can reduce its impact on patients, health systems, and economies worldwide.
-
How Long Can Health Systems Afford to Sideline the Private Sector?
HealthSpark, Episode 24: Tisha Boatman, Executive Vice President of External Affairs at Siemens Healthineers, reflects on how changing funding dynamics, shifting attitudes toward collaboration, and a more ecosystem‑oriented mindset are redefining the role of the private sector in health systems worldwide.
-
When Patients are Hungry, Uninsured, and Scared, What Does High-Quality Care Look Like?
HealthSpark, Episode 23: Mallika Marshall, an internal medicine physician at Massachusetts General Hospital’s Chelsea Urgent Care Clinic and Revere Health Center, explores what it takes to deliver equitable, patient-centered care in the face of profound social and economic barriers.
-
Why are Millions Dying from a Curable Disease?
HealthSpark, Episode 22: Rushdy Ahmad, Director of the Diagnostics Accelerator at Harvard's Wyss Institute, examines why curable diseases like tuberculosis still claim so many lives. He discusses what it will take across science, funding, and policy to get simple tests into the places where people need them most.
-
Are Hospitals Trying to do too Much for too Many Patients?
HealthSpark, Episode 21: Mary Witkowski, Fellow at Harvard Business School's Institute for Strategy & Competitiveness and a member of the teaching faculty at Harvard Medical School, examines how shifting from "do everything" hospitals to condition‑focused care teams can improve outcomes, reduce waste, and create a better experience for both patients and clinicians.
-
How Do We Match the Right Drug to the Right Patient?
HealthSpark, Episode 20: Tanya M. Laidlaw, MD, Professor of Medicine at Harvard Medical School and allergist-immunologist at Brigham and Women’s Hospital, shows how treating severe asthma with advanced biologics can still feel like trial-and-error, and why linking patient experience, biomarkers, and research is critical to getting treatment right the first time.
